Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (51-60 of 414) with videos related to

Pageof 42
Sort By:
Lupus|December 8, 2004
Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosusJ T Merrill
The Lancet. Rheumatology|January 17, 2024
For lupus trials, the answer might depend on the questionJoan T Merrill
Current Rheumatology Reports|December 21, 2000
Clinical trials for the antiphospholipid syndromeJ T Merrill
Current Rheumatology Reports|July 27, 2001
Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodiesJ T Merrill
Rheumatic Diseases Clinics of North America|September 6, 2001
Which antiphospholipid antibody tests are most useful?J T Merrill
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
Ending the 50-year drought of FDA drug approval for SLEJoan T Merrill
Current Rheumatology Reports|March 30, 2006
Do antiphospholipid antibodies develop for a purpose?Joan T Merrill
Expert Opinion on Emerging Drugs|March 11, 2005
Emergence of targeted immune therapies for systemic lupusJoan T Merrill
Nature|April 9, 2004
Earth science: time of reversalRonald T Merrill
Current Rheumatology Reports|July 30, 2008
Topical tacrolimus and pimecrolimus for cutaneous lupusJoan T Merrill
Pageof 42

Showing results (51-60 of 414) with videos related to

Sort By:
Pageof 42
Lupus|December 8, 2004
Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosusJ T Merrill
The Lancet. Rheumatology|January 17, 2024
For lupus trials, the answer might depend on the questionJoan T Merrill
Current Rheumatology Reports|December 21, 2000
Clinical trials for the antiphospholipid syndromeJ T Merrill
Current Rheumatology Reports|July 27, 2001
Appropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodiesJ T Merrill
Rheumatic Diseases Clinics of North America|September 6, 2001
Which antiphospholipid antibody tests are most useful?J T Merrill
Bulletin of the NYU Hospital for Joint Diseases|November 1, 2011
Ending the 50-year drought of FDA drug approval for SLEJoan T Merrill
Current Rheumatology Reports|March 30, 2006
Do antiphospholipid antibodies develop for a purpose?Joan T Merrill
Expert Opinion on Emerging Drugs|March 11, 2005
Emergence of targeted immune therapies for systemic lupusJoan T Merrill
Nature|April 9, 2004
Earth science: time of reversalRonald T Merrill
Current Rheumatology Reports|July 30, 2008
Topical tacrolimus and pimecrolimus for cutaneous lupusJoan T Merrill
Pageof 42